STUDY SUMMARY
Pancreas Cancer Model: TM00176
NSG™ mice engrafted with passage 4 tumors for model TM00176
were randomly assigned to one of these treatment groups:
- 5% dextrose in water (vehicle control; 5 ml/kg; IV once per week for three times; N=8-10)
- 5-FU (30 mg/kg; IV once per week for three times; N=8-10)
- Cisplatin (2 mg/kg; IV once per week for three times; N=8-10)
- Gemcitabine (150 mg/kg; IP once per per week for 3 times; N=8-10)
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups